FDA Approves Novo Nordisk’s Wegovy for Liver Disease

A

AdriΓ  Calatayud

Guest
Novo Nordisk shares climbed after the U.S. Food and Drug Administration approved a new indication for the Danish drugmaker’s blockbuster Wegovy medicine to treat a serious fatty liver disease.

Continue reading...
 


Join 𝕋𝕄𝕋 on Telegram
Channel PREVIEW:
You must log in or register to reply here.
Back
Top